These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8043010)

  • 1. Vaninolol: a new selective beta 1-adrenoceptor antagonist derived from vanillin.
    Wu BN; Hwang TL; Liao CF; Chen IJ
    Biochem Pharmacol; 1994 Jul; 48(1):101-9. PubMed ID: 8043010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new beta-adrenoceptor blocking agent derived from dehydrozingerone.
    Wu BN; Yang CR; Yang JM; Chen IJ
    Gen Pharmacol; 1994 Jul; 25(4):651-9. PubMed ID: 7958725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly selective beta1-adrenergic blocker with partial beta2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch.
    Wu BN; Huang YC; Wu HM; Hong SJ; Chiang LC; Chen IJ
    J Cardiovasc Pharmacol; 1998 May; 31(5):750-7. PubMed ID: 9593075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.
    Chen IJ; Yeh JL; Lo YC; Sheu SH; Lin YT
    Br J Pharmacol; 1996 Sep; 119(1):7-14. PubMed ID: 8872350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomolol: an ultra short-acting and vasorelaxant vanilloid type beta 1-adrenoceptor antagonist.
    Lin YT; Wu BN; Wu JR; Lo YC; Chen LC; Chen IJ
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):149-57. PubMed ID: 8797149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties.
    Lin YT; Wu BN; Horng CF; Huang YC; Hong SJ; Lo YC; Cheng CJ; Chen IJ
    Jpn J Pharmacol; 1999 Jun; 80(2):127-36. PubMed ID: 10440531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
    Chiu CC; Lin YT; Tsai CH; Liang JC; Chiang LC; Wu JR; Chen IJ; Yeh JL
    Gen Pharmacol; 2000 Jun; 34(6):391-400. PubMed ID: 11483288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
    Huang YC; Wu BN; Lin YT; Chen SJ; Chiu CC; Cheng CJ; Chen IJ
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):10-20. PubMed ID: 10413061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanillylamide-based propanolamine derivative displays alpha/beta-adrenoceptor blocking and vasodilating properties.
    Yeh JL; Wu JR; Chiu CC; Chen YW; Lo YC; Lin YT; Cheng CJ; Chen IJ
    J Cardiovasc Pharmacol; 2002 Jun; 39(6):803-13. PubMed ID: 12021574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular hypotensive and vasodilative effects of two beta-adrenergic blockers with intrinsic sympathomimetic activity.
    Hong SJ; Wu KY; Chen IJ
    Curr Eye Res; 1998 Jul; 17(7):700-7. PubMed ID: 9678415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
    Maekawa H
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
    Keith RA; Hwang TF; Murthy VS; Kau ST; Salama AI; Giles RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):240-8. PubMed ID: 2563288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.